Stay updated with breaking news from Beyond drug. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Island Pharmaceuticals Ltd (ASX:ILA) has now dosed all eight subjects in the second cohort of its ISLA-101 Single Ascending Dose (SAD) study. ISLA-101 is a. ....
Island Pharmaceuticals Ltd (ASX:ILA), a leader in antiviral drug development, has initiated the first cohort dosing in its single ascending dose (SAD) study. ....
Island Pharmaceuticals Ltd (ASX:ILA) has officially commenced screening subjects for the ISLA-101 single ascending dose study. The company plans to. ....